All In MedTech

Device Trial Radar · NCT03340142

VIVO™ Accuracy Study

Last checked: Nov 20, 2026Latest source record: Nov 15, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

45

Actual

Start

Jan 29, 2018

Primary completion

Sep 4, 2018

Study completion Nov 1, 2018

Sponsor

Lead sponsor
Catheter Precision. Inc.Not on our public-company list
Sponsor type
Industry
First posted
Nov 13, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A multi-center study designed to assess the accuracy of VIVO™ in determining the location of a PVC/VT foci in comparison to an electroanatomical mapping system.

Conditions

  • Premature Ventricular Contraction
  • Ventricular Tachycardia

Interventions

  • VIVO™Device

    Diagnose the area of a PVC or VT onset

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Accuracy of correctly identifying PVC or VT originTime frame: 1 Day

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • University of Iowa

    Iowa City, Iowa

  • Johns Hopkins Unveristy

    Baltimore, Maryland

  • Medical Unversity of South Carolina

    Charleston, South Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.